Literature DB >> 17304513

Inactivation of LLC1 gene in nonsmall cell lung cancer.

Kyeong-Man Hong1, Sei-Hoon Yang, Sinchita Roy Chowdhuri, Audrey Player, Megan Hames, Junya Fukuoka, Daoud Meerzaman, Tatiana Dracheva, Zhifu Sun, Ping Yang, Jin Jen.   

Abstract

Serial analysis of gene expression studies led us to identify a previously unknown gene, c20orf85, that is present in the normal lung epithelium but absent or downregulated in most primary nonsmall cell lung cancers and lung cancer cell lines. We named this gene LLC1 for Low in Lung Cancer 1. LLC1 is located on chromosome 20q13.3 and has a 70% GC content in the promoter region. It has 4 exons and encodes a protein containing 137 amino acids. By in situ hybridization, we observed that LLC1 message is localized in normal lung bronchial epithelial cells but absent in 13 of 14 lung adenocarcinoma and 9 out of 10 lung squamous carcinoma samples. Methylation at CpG sites of the LLC1 promoter was frequently observed in lung cancer cell lines and in a fraction of primary lung cancer tissues. Treatment with 5-aza deoxycytidine resulted in a reduced methylation of the LLC1 promoter concomitant with the increase of LLC1 expression. These results suggest that inactivation of LLC1 by means of promoter methylation is a frequent event in nonsmall cell lung cancer and may play a role in lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304513      PMCID: PMC1907378          DOI: 10.1002/ijc.22577

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

Review 1.  Gene silencing in cancer in association with promoter hypermethylation.

Authors:  James G Herman; Stephen B Baylin
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

2.  L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma.

Authors:  T Wang; L Fan; Y Watanabe; P McNeill; G R Fanger; D H Persing; S G Reed
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

3.  Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

Authors:  Charles R Holst; Gerard J Nuovo; Manel Esteller; Karen Chew; Stephen B Baylin; James G Herman; Thea D Tlsty
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

4.  Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.

Authors:  Angelo Agathanggelou; Ashraf Dallol; Sabine Zöchbauer-Müller; Catherine Morrissey; Sofia Honorio; Luke Hesson; Tommy Martinsson; Kwun M Fong; Michael J Kuo; Po Wing Yuen; Eamonn R Maher; John D Minna; Farida Latif
Journal:  Oncogene       Date:  2003-03-13       Impact factor: 9.867

5.  Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

Authors:  Junya Fukuoka; Takeshi Fujii; Joanna H Shih; Tatiana Dracheva; Daoud Meerzaman; Audrey Player; Kyeong Hong; Sharon Settnek; Ajay Gupta; Kenneth Buetow; Stephen Hewitt; William D Travis; Jin Jen
Journal:  Clin Cancer Res       Date:  2004-07-01       Impact factor: 12.531

6.  Identification of TDE2 gene and its expression in non-small cell lung cancer.

Authors:  Audrey Player; John Gillespie; Takeshi Fujii; Junya Fukuoka; Tatiana Dracheva; Dauod Meerzaman; Kyeong Man Hong; John Curran; Goziam Attoh; William Travis; Jin Jen
Journal:  Int J Cancer       Date:  2003-11-01       Impact factor: 7.396

Review 7.  Genome amplification of chromosome 20 in breast cancer.

Authors:  J Graeme Hodgson; Koei Chin; Colin Collins; Joe W Gray
Journal:  Breast Cancer Res Treat       Date:  2003-04       Impact factor: 4.872

8.  Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.

Authors:  Takaomi Koga; Yoshitsugu Horio; Tetsuya Mitsudomi; Takashi Takahashi; Yasushi Yatabe
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

9.  Gene-expression profiles predict survival of patients with lung adenocarcinoma.

Authors:  David G Beer; Sharon L R Kardia; Chiang-Ching Huang; Thomas J Giordano; Albert M Levin; David E Misek; Lin Lin; Guoan Chen; Tarek G Gharib; Dafydd G Thomas; Michelle L Lizyness; Rork Kuick; Satoru Hayasaka; Jeremy M G Taylor; Mark D Iannettoni; Mark B Orringer; Samir Hanash
Journal:  Nat Med       Date:  2002-07-15       Impact factor: 53.440

10.  SAGE mRNA expression in advanced-stage lung cancers.

Authors:  H Sasaki; S Moriyama; K Mizuno; H Yukiue; M Yano; I Fukai; Y Yamakawa; Y Fujii
Journal:  Eur J Surg Oncol       Date:  2003-12       Impact factor: 4.424

View more
  6 in total

1.  Epigenetic inactivation of SOX1 promotes cell migration in lung cancer.

Authors:  Ning Li; Suyun Li
Journal:  Tumour Biol       Date:  2015-01-23

2.  Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.

Authors:  Kang-Seo Park; Hyun-Kyoung Kim; Jung-Hwa Lee; Yong-Bock Choi; Seong-Yeol Park; Sei-Hoon Yang; Soo-Youl Kim; Kyeong-Man Hong
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-18       Impact factor: 4.553

3.  Schistosoma mansoni Egg, Adult Male and Female Comparative Gene Expression Analysis and Identification of Novel Genes by RNA-Seq.

Authors:  Letícia Anderson; Murilo S Amaral; Felipe Beckedorff; Lucas F Silva; Bianca Dazzani; Katia C Oliveira; Giulliana T Almeida; Monete R Gomes; David S Pires; João C Setubal; Ricardo DeMarco; Sergio Verjovski-Almeida
Journal:  PLoS Negl Trop Dis       Date:  2015-12-31

Review 4.  Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Authors:  Michela Coan; Gian Luca Rampioni Vinciguerra; Laura Cesaratto; Emanuela Gardenal; Riccardo Bianchet; Erik Dassi; Andrea Vecchione; Gustavo Baldassarre; Riccardo Spizzo; Milena Sabrina Nicoloso
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

5.  Comparative analysis of methods for identifying recurrent copy number alterations in cancer.

Authors:  Xiguo Yuan; Junying Zhang; Shengli Zhang; Guoqiang Yu; Yue Wang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

6.  Novel Approach Combining Transcriptional and Evolutionary Signatures to Identify New Multiciliation Genes.

Authors:  Audrey Defosset; Dorine Merlat; Laetitia Poidevin; Yannis Nevers; Arnaud Kress; Olivier Poch; Odile Lecompte
Journal:  Genes (Basel)       Date:  2021-09-21       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.